← Leaderboards
James H Woods
University Of Michigan At Ann Arbor
$18,938,311
Attributed
$21,323,043
Total exposure
15
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.9M · FY2005–21$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$26,356,516 · 16
By mechanism
R01$14,426,763 · 9
P50$6,945,223 · 6
P01$4,984,530 · 1
Top collaborators
- Donald W Landry5 shared
- Chang-Guo Zhan5 shared
- William P Clarke3 shared
Most similar at University Of Michigan At Ann Arbor
Same institution · by research overlap
- Ao-Lin Allen Hsu$6,621,096
- Emily M Jutkiewicz$3,827,799
- Henry Isaac Mosberg$11,490,941
- Lindsay Yager$65,468
- Remy L. Brim$33,937
Others in their field
Top investigators on “Cocaine”
- Sten H Vermund · University Of Alabama At Birmingham$115,253,143
- Fred M Gordin · Social And Scientific Systems, Inc.$44,160,542
- Eric J Nestler · Icahn School Of Medicine At Mount Sinai$42,690,128
- Joel Gelernter · Washington University$34,364,949
- Michael A Nader · Emory University$33,226,167
- Shenghan Lai · University Of Miami Coral Gables$31,568,530
Research focus
CocaineBehavioralDesignPharmaceutical PreparationsEvaluationIn VivoIn VitroOpioid ReceptorMacaca MulattaRattusBasePreventLeadToxic EffectBehavioral /Social Science Research TagDoseReceptorAgonistProceduresPsychopharmacologyAdverse EffectsImmunogenicityCocaine EsteraseEnzymes
Grant awards (49)
Pharmacological and behavioral effects of MCAM: a long-acting, μ opioid receptor antagonist for treatment of opioid overdose and opioid abuse disorder$461,788
R01 · FY2021 · DA
Pharmacological and behavioral effects of MCAM: a long-acting, μ opioid receptor antagonist for treatment of opioid overdose and opioid abuse disorder$461,788
R01 · FY2020 · DA
Pharmacological and behavioral effects of MCAM: a long-acting, μ opioid receptor antagonist for treatment of opioid overdose and opioid abuse disorder$461,788
R01 · FY2019 · DA
Preclinical Identification of Better Antimuscarinic Antidepressants$542,032
R01 · FY2018 · MH · contact PI
Preclinical Identification of Better Antimuscarinic Antidepressants$590,827
R01 · FY2017 · MH · contact PI
Preclinical Identification of Better Antimuscarinic Antidepressants$617,070
R01 · FY2016 · MH · contact PI
High-activity mutants of cocaine esterase for treatment of drug addiction$549,174
R01 · FY2012 · DA
Dopamine D2/D3 Receptors in Compulsive Disorders$461,120
R01 · FY2012 · DA · contact PI
High-activity mutants of cocaine esterase for treatment of drug addiction$499,768
R01 · FY2011 · DA
Dopamine D2/D3 Receptors in Compulsive Disorders$460,317
R01 · FY2011 · DA · contact PI
High-activity mutants of cocaine esterase for treatment of drug addiction$500,218
R01 · FY2010 · DA
Dopamine D2/D3 Receptors in Compulsive Disorders$466,247
R01 · FY2010 · DA · contact PI
Development of Esterases for the Treatment of Cocaine Overdose and Abuse$705,170
R01 · FY2009 · DA · contact PI
High-activity mutants of cocaine esterase for treatment of drug addiction$489,970
R01 · FY2009 · DA
Dopamine D2/D3 Receptors in Compulsive Disorders$399,761
R01 · FY2009 · DA · contact PI
Development of Esterases for the Treatment of Cocaine Overdose and Abuse$684,627
R01 · FY2008 · DA · contact PI
High-activity mutants of cocaine esterase for treatment of drug addiction$498,945
R01 · FY2008 · DA
Development of Esterases for the Treatment of Cocaine Overdose and Abuse$678,251
R01 · FY2007 · DA · contact PI
Narcotic Drug and Opioid Peptide Basic Research project$1,153,664
P01 · FY2006 · DA · contact PI
Development of Esterases for the Treatment of Cocaine Overdose and Abuse$704,821
R01 · FY2006 · DA · contact PI
Narcotic Drug and Opioid Peptide Basic Research project$1,310,342
P01 · FY2005 · DA
CRH Antagonists for Treatment of Drug Abuse$329,183
R01 · FY2005 · DA
Stress, Rearing, and Ethanol Reinforcement in Monkeys$306,000
R01 · FY2005 · AA
Narcotic Drug and Opioid Peptide Basic Research project$1,243,955
P01 · FY2004 · DA
CRH Antagonists for Treatment of Drug Abuse$329,781
R01 · FY2004 · DA
Stress, Rearing, and Ethanol Reinforcement in Monkeys$306,000
R01 · FY2004 · AA
Narcotic Drug and Opioid Peptide Basic Research project$1,276,569
P01 · FY2003 · DA
EVALUATION OF PROTEIN BASED MEDICATIONS AGAINST COCAINE$410,438
R01 · FY2003 · DA
CRH Antagonists for Treatment of Drug Abuse$330,202
R01 · FY2003 · DA
Stress, Rearing, and Ethanol Reinforcement in Monkeys$306,000
R01 · FY2003 · AA
Narcotic Drug and Opioid Peptide Basic Research Project$1,578,746
P50 · FY2002 · DA
EVALUATION OF PROTEIN BASED MEDICATIONS AGAINST COCAINE$398,880
R01 · FY2002 · DA
CRH Antagonists for Treatment of Drug Abuse$326,958
R01 · FY2002 · DA
BCHE as a Cocaine Antagonist$252,592
R01 · FY2002 · DA
Narcotic Drug and Opioid Peptide Basic Research Project$1,442,396
P50 · FY2001 · DA
BCHE as a Cocaine Antagonist$495,882
R01 · FY2001 · DA
EVALUATION OF PROTEIN BASED MEDICATIONS AGAINST COCAINE$401,165
R01 · FY2001 · DA
NARCOTIC DRUG AND OPIOID PEPTIDE BASIC RESEARCH PROJECT$1,771,358
P50 · FY2000 · DA
NARCOTIC DRUG AND OPIOID PEPTIDE BASIC RESEARCH PROJECT$240,973
P50 · FY2000 · DA
EFFECTS OF OPIOIDS ON RESPIRATION$191,175
P50 · FY2000 · DA
RESPONDING MAINTAINED WITH FOOD OR STIMULUS SHOCK TERMINATION$191,175
P50 · FY2000 · DA
RESPONDING MAINTAINED WITH FOOD OR STIMULUS SHOCK TERMINATION$191,175
P50 · FY2000 · DA
ANALGESIA$191,175
P50 · FY2000 · DA
EFFECTS OF OPIOIDS ON RESPIRATION$191,175
P50 · FY2000 · DA
DISCRIMINATIVE STIMULUS EFFECTS OF OPIOID DRUG$191,175
P50 · FY2000 · DA
DISCRIMINATIVE STIMULUS EFFECTS OF OPIOID DRUG$191,175
P50 · FY2000 · DA
MOUSE IN VIVO STUDIES$191,175
P50 · FY2000 · DA
MOUSE IN VIVO STUDIES$191,175
P50 · FY2000 · DA
ANALGESIA$191,175
P50 · FY2000 · DA